Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

Masimo (NASDAQ:MASI) Corporation (NASDAQ:MASI), a medical technology company, has announced the termination of its Chief Executive Officer, Joe Kiani, effective October 24, 2024. The decision was ...

According to a regulatory filing, following a review by outside counsel, on October 24, 2024, the Board of Directors of Masimo (MASI) adopted resolutions to terminate the employment of Masimo’s ...

Masimo (NASDAQ: MASI) today announced that Vanderbilt University Medical Center (VUMC), a renowned healthcare facility in ...

Masimo has filed a lawsuit against its founder and former CEO Joe Kiani and investment firm RTW Investments, accusing them of illegally manipulating a recent shareholder vote. The suit, filed in ...

Apple convinced a federal jury on Friday that early versions of health monitoring tech company Masimo's smartwatches infringe two of its design patents as part of a broader intellectual property ...

Masimo, a California-based company, had earlier accused Apple of poaching its employees and appropriating its pulse oximetry technology after initial talks regarding a potential partnership. The US ...

At the beginning of the year, the U.S. International Trade Commission ruled in favor of Masimo, saying Apple’s use of pulse oximeter technology in the Apple Watch violated Masimo’s patents.

This is the latest development in the long legal battle between Masimo, a medical tech firm, and Apple in which the former alleges the latter unlawfully incorporated its pulse oximetry tech into the ...

The intense legal feud between Apple and medical technology company Masimo has reached a pivotal moment with Apple winning a nominal victory in the latest round of court battles. A federal jury ...

Irvine, California-based After discussing a potential collaboration, Masimo accused Apple of firing its employees and stealing its pulse oximetry technology. Apple and Masimo Continue Legal Battle ...